Clinical Trial Update: IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating interferon-gamma (IFN-γ) for relapsed myelodysplastic syndrome and acute myeloid leukemia after allogeneic stem cell transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: Sawa Ito, MD | Conditions: Myelodysplastic Syndromes, Myeloid Leukemia | EARLY_Phase 1 | Status: COMPLETED